1BSQ
| STRUCTURAL AND FUNCTIONAL CONSEQUENCES OF POINT MUTATIONS OF VARIANTS A AND B OF BOVINE BETA-LACTOGLOBULIN | Descriptor: | PROTEIN (BETA-LACTOGLOBULIN) | Authors: | Qin, B.Y, Creamer, L.K, Bewley, M.C, Baker, E.N, Jameson, G.B. | Deposit date: | 1998-08-29 | Release date: | 1998-09-02 | Last modified: | 2024-04-03 | Method: | X-RAY DIFFRACTION (2.22 Å) | Cite: | Functional implications of structural differences between variants A and B of bovine beta-lactoglobulin. Protein Sci., 8, 1999
|
|
7MFY
| |
1BRP
| |
7MFZ
| |
7MFX
| |
1BWY
| NMR STUDY OF BOVINE HEART FATTY ACID BINDING PROTEIN | Descriptor: | PROTEIN (HEART FATTY ACID BINDING PROTEIN) | Authors: | Lassen, D, Luecke, C, Kveder, M, Mesgarzadeh, A, Schmidt, J.M, Specht, B, Lezius, A, Spener, F, Rueterjans, H. | Deposit date: | 1998-09-29 | Release date: | 1998-10-07 | Last modified: | 2024-04-10 | Method: | SOLUTION NMR | Cite: | Three-dimensional structure of bovine heart fatty-acid-binding protein with bound palmitic acid, determined by multidimensional NMR spectroscopy. Eur.J.Biochem., 230, 1995
|
|
1BRQ
| |
1CBI
| APO-CELLULAR RETINOIC ACID BINDING PROTEIN I | Descriptor: | CELLULAR RETINOIC ACID BINDING PROTEIN I | Authors: | Thompson, J.R, Bratt, J.M, Banaszak, L.J. | Deposit date: | 1995-07-12 | Release date: | 1995-11-14 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (2.7 Å) | Cite: | Crystal structure of cellular retinoic acid binding protein I shows increased access to the binding cavity due to formation of an intermolecular beta-sheet. J.Mol.Biol., 252, 1995
|
|
7O0K
| |
7O0J
| |
7NRW
| Human myelin protein P2 mutant M114T | Descriptor: | CHLORIDE ION, MAGNESIUM ION, Myelin P2 protein, ... | Authors: | Uusitalo, M, Ruskamo, S, Kursula, P. | Deposit date: | 2021-03-04 | Release date: | 2021-09-01 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Human myelin protein P2: from crystallography to time-lapse membrane imaging and neuropathy-associated variants. Febs J., 288, 2021
|
|
7NSR
| Myelin protein P2 I50del | Descriptor: | CHLORIDE ION, MAGNESIUM ION, Myelin P2 protein, ... | Authors: | Uusitalo, M, Ruskamo, S, Kursula, P. | Deposit date: | 2021-03-08 | Release date: | 2021-09-01 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.5 Å) | Cite: | Human myelin protein P2: from crystallography to time-lapse membrane imaging and neuropathy-associated variants. Febs J., 288, 2021
|
|
7NTP
| Human myelin P2 mutant V115A | Descriptor: | Myelin P2 protein, PALMITIC ACID | Authors: | Uusitalo, M, Ruskamo, S, Kursula, P. | Deposit date: | 2021-03-10 | Release date: | 2021-09-01 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (2.1 Å) | Cite: | Human myelin protein P2: from crystallography to time-lapse membrane imaging and neuropathy-associated variants. Febs J., 288, 2021
|
|
7NQB
| |
7O60
| Crystal structure of human myelin protein P2 at room temperature from joint X-ray and neutron refinement. | Descriptor: | CITRIC ACID, Myelin P2 protein, PALMITIC ACID | Authors: | Laulumaa, S, Blakeley, M.P, Kursula, P. | Deposit date: | 2021-04-09 | Release date: | 2021-09-01 | Last modified: | 2021-12-15 | Method: | NEUTRON DIFFRACTION (2 Å), X-RAY DIFFRACTION | Cite: | Human myelin protein P2: from crystallography to time-lapse membrane imaging and neuropathy-associated variants. Febs J., 288, 2021
|
|
7OUB
| |
5NGH
| |
6QI7
| Engineered beta-lactoglobulin: variant L39Y in complex with endogenous ligand | Descriptor: | 1,2-ETHANEDIOL, Beta-lactoglobulin, PALMITIC ACID | Authors: | Loch, J.I, Siuda, M.K, Lewinski, K. | Deposit date: | 2019-01-17 | Release date: | 2019-01-30 | Last modified: | 2024-01-24 | Method: | X-RAY DIFFRACTION (2.5 Å) | Cite: | Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
|
|
5NKN
| Crystal structure of an Anticalin-colchicine complex | Descriptor: | N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[d]heptalen-7-yl]ethanamide, Neutrophil gelatinase-associated lipocalin | Authors: | Skerra, A, Eichinger, A, Barkovskiy, M. | Deposit date: | 2017-03-31 | Release date: | 2018-04-04 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | An engineered lipocalin that tightly complexes the plant poison colchicine for use as antidote and in bioanalytical applications. Biol. Chem., 400, 2019
|
|
5NU2
| |
5NUA
| |
5NUN
| Engineered beta-lactoglobulin: variant F105L-L39A-M107F in complex with chlorpromazine (LG-LAF-CLP) | Descriptor: | 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine, Beta-lactoglobulin | Authors: | Loch, J.I, Bonarek, P, Towrzydlo, M, Lazinskia, I, Szydlowska, J, Lewinski, K. | Deposit date: | 2017-04-30 | Release date: | 2018-04-04 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.95 Å) | Cite: | The engineered beta-lactoglobulin with complementarity to the chlorpromazine chiral conformers. Int. J. Biol. Macromol., 114, 2018
|
|
5NTY
| |
5NU6
| |
5NUM
| Engineered beta-lactoglobulin: variant F105L-L39A in complex with chlorpromazine (LG-LA-CLP) | Descriptor: | 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine, Beta-lactoglobulin, PHOSPHATE ION | Authors: | Loch, J.I, Bonarek, P, Tworzydlo, M, Lazinska, I, Szydlowska, J, Lewinski, K. | Deposit date: | 2017-04-30 | Release date: | 2018-04-04 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (2.3 Å) | Cite: | The engineered beta-lactoglobulin with complementarity to the chlorpromazine chiral conformers. Int. J. Biol. Macromol., 114, 2018
|
|